Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-10-10
1998-05-05
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 72, 536 73, 536 74, A61K 3170, C07H 1708
Patent
active
057474664
ABSTRACT:
A compound selected from the group: ##STR1## wherein A, B, V, W, X and R.sup.8 are specifically defined; pharmaceutical compositions thereof; a method of treating or preventing bacterial infections by administering therapeutically effective pharmaceutical compositions thereof; and a process for the preparation thereof.
REFERENCES:
patent: 4331803 (1982-05-01), Watanabe et al.
patent: 5141926 (1992-08-01), Weber et al.
patent: 5403923 (1995-04-01), Kashimura et al.
Journal of Medicinal Chemistry, vol. 17 (1974), pp. 953-956, R. A. LeMahieu, et al. "Glycoside Cleavage Reactions on Erythromycin A. Preparation of Erythromycin A".
Chu Daniel T.
Elliott Richard L.
Or Yat Sun
Pireh Daisy
Abbott Laboratories
Anand Mona
Peselev Elli
LandOfFree
3-deoxy-3-descladinose derivatives of erythromycins A and B does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-deoxy-3-descladinose derivatives of erythromycins A and B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-deoxy-3-descladinose derivatives of erythromycins A and B will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54663